These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23213181)

  • 1. Assessing cancer with a blood draw.
    Azvolinsky A
    J Natl Cancer Inst; 2012 Dec; 104(23):1774-5. PubMed ID: 23213181
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating tumour-derived predictive biomarkers in oncology.
    Hodgson DR; Wellings R; Orr MC; McCormack R; Malone M; Board RE; Cantarini MV
    Drug Discov Today; 2010 Feb; 15(3-4):98-101. PubMed ID: 20045486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Cancer Conference: targeted therapies boom expected in 3-5 years.
    Gethins M
    J Natl Cancer Inst; 2011 Oct; 103(20):1491-3. PubMed ID: 21972228
    [No Abstract]   [Full Text] [Related]  

  • 5. The potential of circulating nucleic acids as components of companion diagnostics for predicting and monitoring chemotherapy response.
    Schwarzenbach H
    Expert Rev Mol Diagn; 2015 Feb; 15(2):267-75. PubMed ID: 25382372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities and limitations of stratified medicine based on biomarkers and targeted therapies in oncology].
    Ludwig WD
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(1):11-22. PubMed ID: 22325103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetic tumor markers and their analysis for diagnosis and therapy of cancer patients].
    Ianov IuK; Novik AA; Belokhvostov AS
    Klin Med (Mosk); 1999; 77(11):4-9. PubMed ID: 10635622
    [No Abstract]   [Full Text] [Related]  

  • 8. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis.
    Kin C; Kidess E; Poultsides GA; Visser BC; Jeffrey SS
    Expert Rev Mol Diagn; 2013 Jul; 13(6):581-99. PubMed ID: 23895128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
    Esposito A; Bardelli A; Criscitiello C; Colombo N; Gelao L; Fumagalli L; Minchella I; Locatelli M; Goldhirsch A; Curigliano G
    Cancer Treat Rev; 2014 Jun; 40(5):648-55. PubMed ID: 24184333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating cell-free DNA as biomarker for cancer *header*].
    Isomursu A; Kononen J; Kuopio T
    Duodecim; 2015; 131(5):424-32. PubMed ID: 26237904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extracellular DNA in plasma--a potential diagnostic marker in oncology].
    Gaziev AI; Shaĭhaev GO; Korenev SV
    Vopr Onkol; 2008; 54(5):545-54. PubMed ID: 19069466
    [No Abstract]   [Full Text] [Related]  

  • 13. Colorectal cancer stem cells as biomarkers: where it all starts?
    Avital I; Summers TA; Steele SR; Waldman S; Nissan A; Bilchik AJ; Protic M; Man YG; Brücher BL; Stojadinovic A
    J Surg Oncol; 2013 Jun; 107(8):791-3. PubMed ID: 23512573
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA methylation defects in sporadic and hereditary colorectal cancer].
    Xicola RM; Llor X
    Gastroenterol Hepatol; 2012; 35(7):480-7. PubMed ID: 22459641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients.
    Frattini M; Balestra D; Verderio P; Gallino G; Leo E; Sozzi G; Pierotti MA; Daidone MG
    J Clin Oncol; 2005 May; 23(13):3163-4; author reply 3164-5. PubMed ID: 15860889
    [No Abstract]   [Full Text] [Related]  

  • 17. Biospecimen banking: the pathway to personalized medicine for patients with cancer.
    Scolyer RA; Thompson JF
    J Surg Oncol; 2013 Jun; 107(7):681-2. PubMed ID: 23280671
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in biomarkers for targeted agents.
    Maitland ML
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):688-90. PubMed ID: 22402514
    [No Abstract]   [Full Text] [Related]  

  • 19. [Molecular targeted cancer therapy and genetic tests --chairman's introductory remarks].
    Hinoda Y
    Rinsho Byori; 2012 Oct; 60(10):967-8. PubMed ID: 23323461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Signal transduction and its targeting from the cancer molecular genetic platform: applications and perspectives in pulmonary pathology].
    Merlio JP
    Ann Pathol; 2011 Nov; 31(5 Suppl):S40-2. PubMed ID: 22054456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.